Literature DB >> 8125242

Increase of capsular material thickness following in vivo growth of virulent Streptococcus suis serotype 2 strains.

S Quessy1, J D Dubreuil, M Jacques, F Malouin, R Higgins.   

Abstract

Protein profile and capsular material thickness of Streptococcus suis serotype 2 strains were compared after in vitro and in vivo growth. Three virulent and one avirulent strains were used. These strains were grown in Brain Heart Infusion (BHI) broth, cells were collected by centrifugation, resuspended in a sterile saline solution and injected in diffusion chambers. The devices were then inserted in rat abdomens for 17 h. In vitro grown strains were also inoculated into fresh BHI broth and cultivated for 17 h at 37 degrees C. In vivo as well as in vitro grown bacteria were harvested by centrifugation, processed in a French pressure cell, treated with lysozyme and centrifuged to collect cell proteins for SDS-PAGE analysis. Transmission electron microscopy using polycationic ferritin labeling to stabilize capsular material was also carried out. No significant modification was noted in the protein profile for any strain after in vivo growth except for a 39 kDa protein of one virulent strain. On the other hand, an increase in thickness of capsular material was noted for the three in vivo grown virulent strains while no change was noted for the avirulent strain. This increase in capsular material thickness of virulent strains was accompanied by an increased resistance to killing by pig polymorphonuclear leukocytes. The capacity to produce more capsular material in vivo seems to be an attribute of some virulent S. suis serotype 2 strains.

Entities:  

Mesh:

Year:  1994        PMID: 8125242     DOI: 10.1111/j.1574-6968.1994.tb06608.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  9 in total

1.  Immunization of pigs against Streptococcus suis serotype 2 infection using a live avirulent strain.

Authors:  P Busque; R Higgins; F Caya; S Quessy
Journal:  Can J Vet Res       Date:  1997-10       Impact factor: 1.310

2.  Associations of Streptococcus suis serotype 2 ribotype profiles with clinical disease and antimicrobial resistance.

Authors:  S R Rasmussen; F M Aarestrup; N E Jensen; S E Jorsal
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

3.  Increase of glycocalyx and altered lectin agglutination profiles of Pasteurella haemolytica A1 after incubation in bovine subcutaneous tissue chambers in vivo or in ruminant serum in vitro.

Authors:  K Brogden; C Clarke
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

4.  Immunization of mice against Streptococcus suis serotype 2 infections using a live avirulent strain.

Authors:  S Quessy; J D Dubreuil; R Higgins
Journal:  Can J Vet Res       Date:  1994-10       Impact factor: 1.310

5.  Identification and characterization of the cps locus of Streptococcus suis serotype 2: the capsule protects against phagocytosis and is an important virulence factor.

Authors:  H E Smith; M Damman; J van der Velde; F Wagenaar; H J Wisselink; N Stockhofe-Zurwieden; M A Smits
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

6.  Use of ribotyping and hemolysin activity to identify highly virulent Streptococcus suis type 2 isolates.

Authors:  J J Staats; B L Plattner; J Nietfeld; S Dritz; M M Chengappa
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

7.  The galactosyl-(alpha 1-4)-galactose-binding adhesin of Streptococcus suis: occurrence in strains of different hemagglutination activities and induction of opsonic antibodies.

Authors:  K Tikkanen; S Haataja; J Finne
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

Review 8.  Streptococcus suis: past and present.

Authors:  J J Staats; I Feder; O Okwumabua; M M Chengappa
Journal:  Vet Res Commun       Date:  1997-08       Impact factor: 2.459

9.  Purification and characterization of a 52-kilodalton immunoglobulin G-binding protein from Streptococcus suis capsular type 2.

Authors:  B Serhir; D Dubreuil; R Higgins; M Jacques
Journal:  J Bacteriol       Date:  1995-07       Impact factor: 3.490

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.